Tag: #CLABF
Core One Labs Completes Acquisition of Ketamine Infusions Centers of Texas Representing the Company’s First Psychedelics Clinic in the U.S. and Announces Fast Entry Inclusion in the Horizons Psychedelic ETF
Core One Labs Appoints Dr. Stephen Peach as Head of Patient Research
Core One Labs to Commence Trading in the US on OTC Pink Market
Psychedelic Expert Core One Labs Reports Milestone Acquisition
Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy
Core One Labs’ Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvão to License Bioynthesized Psilocybin in Brazil
Core One Labs Highlights Key Points from International Investor Call
